Zealand Pharma — Juli 2023
-
Det er for mig mærkeligt, at shorter har satset på ZP i den seneste tid. Man skal aldrig sige aldrig, men umiddelbart er der ingen risiko for dårlige nyheder i nærmeste fremtid af større karakter (tror jeg). Så skulle det være at BI dropper opstart af fase 3. Eller Glepaglutide viser noget dårligt her i EASE3 /4.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind